BioSpace News Archive

Champions Oncology, Inc., a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the third quarter ended January 31, 2022, on Tuesday, March 15, 2022, after market close.

Altamira Therapeutics Ltd., a company dedicated to developing therapeutics that address important unmet medical needs, announced positive efficacy data from testing its Bentrio™ nasal spray in vitro against the Omicron variant of the SARS-CoV-2 virus.

The global orthodontics market size is predicted to be worth around US$ 16.2 billion by 2028 from valued at US$ 5.99 billion in 2021, growing at a CAGR of 15.3% from 2021 to 2030.

The global sleep apnea devices market is expected to reach valuation of around US$ 10.1 billion by 2027, expanding growth at a CAGR of 7.1% during forecast period 2022 to 2027.

AbbVie and Gedeon Richter Plc. announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases.

Capricor Therapeutics (NASDAQ: CAPR), announced today that The Lancet, a renowned peer-reviewed global medical source for clinical and global health, has published positive results from Capricor’s HOPE-2 Phase 2 clinical trial using lead asset, CAP-1002, to treat patients in advanced stages of Duchenne muscular dystrophy (DMD).

Amyris, Inc. today announced that it has closed the acquisition of the assets of MenoLabs, LLC.

Dermavant Sciences today announced that new data from the Phase 3 PSOARING 3 long-term extension study of tapinar cream.

Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced it will celebrate its recent listing on the Nasdaq Stock Market by ringing the Nasdaq Closing Bell in Times Square, New York City.

The global health coach market size is projected to hit around USD 25.95 billion by 2030 from valued at USD 14.48 billion in 2021, registered growth at a CAGR of 6.7% from 2022 to 2030.